drugset / Trial / NCT05309499

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function

NCT05309499

Completed 298 enrolled Kazan State Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The OPERA-MI trial evaluates the effect of i.v. ferric carboxymaltose compared to the effect of oral iron, on left ventricular systolic function.

Timeline

Start
2021-12-05
Primary completion
2025-09-15
Completion
2025-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 100 mg Oral